The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
If you are interested in our services, please do not hesitate to contact us at any time or submit an inquiry to us directly
Dietary essential fatty acids and brain function: a developmental perspective on mechanisms
Apr 28th, 2026 How IGF-1 LR3 Promotes Muscle Growth and Recovery IGF-1 LR3 is a synthetic, long-acting form of IGF-1 that may promote muscle growth and recovery by increasing protein synthesis, but it is not FDA-approved and lacks strong human evidence in healthy individuals
J Appl Crystallogr 26, 283291 (1993)
Who Can Benefit from Glutathione Injections